Actively Recruiting
EHRA-PATHS: Clinical and Health Economic Evaluation of New Care Pathways
Led by University Medical Center Groningen · Updated on 2024-12-13
1300
Participants Needed
1
Research Sites
92 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In elderly atrial fibrillation (AF) patients, AF is usually a manifestation of risk factors and comorbidities not only limited to cardiovascular diseases. Especially in elderly often more than two comorbidities are present. The presence of comorbidities also affects outcomes in AF patients. Current healthcare systems are single-disease focused, which increases the risk of underdiagnosing, replicating diagnostic tests and adverse drug-drug interactions, placing a high burden on healthcare costs. Healthcare systems and hospitals are in need of new care pathways to address the complexity of multimorbid AF patients and to reduce costs. The EHRA-PATHS consortium set out to address this need for change in management for multimorbid, elderly AF patients in Europe through the development of new care pathways. The aim of this study is to evaluate the current management of risk factors and comorbidities, and subsequently implement the newly developed care pathways and evaluate if these pathways lead to better management of risk factors and comorbidities in multimorbid, elderly AF patients, compared to current standard care.
CONDITIONS
Official Title
EHRA-PATHS: Clinical and Health Economic Evaluation of New Care Pathways
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Newly diagnosed atrial fibrillation (paroxysmal, persistent, or permanent)
- 65 years of age or older
- Willing and able to participate and attend scheduled follow-up visits
You will not qualify if you...
- Atrial fibrillation episode caused by a trigger such as postoperative event, infection, or hyperthyroidism
- Life expectancy less than 1 year
- Participation in another clinical study (registry studies not included)
- Severe cognitive impairment or dementia as defined by MMSE and CDR scoring systems
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Medical Center Groningen
Groningen, Netherlands
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here